Viking Therapeutics (VKTX) Change in Accured Expenses (2014 - 2026)
Viking Therapeutics' (VKTX) quarterly Change in Accured Expenses came in at $1.3 million in Q2 2026, down 90.84% year-over-year from $14.6 million in Q2 2025, and down 91.55% quarter-over-quarter from $15.9 million in Q1 2026.
Powered by 
Analysis
Viking Therapeutics (VKTX) Change in Accured Expenses (2014 - 2026) Analysis & Trends
Viking Therapeutics has disclosed Change in Accured Expenses across 13 years of filings, most recently posting $1.3 million for Q2 2026.
- In Q2 2026, Change in Accured Expenses fell 90.84% year-over-year to $1.3 million; the TTM figure through Jun 2026 stood at $14.5 million (up 17.17% YoY), while the FY2025 annual figure was $6.2 million, up 6.05% from the prior year.
- Change in Accured Expenses came in at $1.3 million for Q2 2026 at Viking Therapeutics, down from $15.9 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $15.9 million in Q1 2024 to a low of -$13.6 million in Q2 2024.
- Average Change in Accured Expenses over 5 years is $1.8 million, with a median of $1.0 million recorded in 2022.
- Year-over-year, Change in Accured Expenses plunged 862.72% in 2023 and surged 6472.88% in 2024.
- Over 5 years, Change in Accured Expenses stood at $2.5 million in 2022, then jumped by 57.26% to $3.9 million in 2023, then slumped by 299.8% to -$7.8 million in 2024, then surged by 126.37% to $2.1 million in 2025, then plunged by 35.09% to $1.3 million in 2026.
- Per Business Quant data, the three most recent Change in Accured Expenses figures were $1.3 million in Q2 2026, $15.9 million in Q1 2026, and $2.1 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 2.32 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | 1.20 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | - |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 852.00 Mn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | 338.00 Mn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 222.50 Mn |
| 10 | Viking Therapeutics | 4.86 Bn | 4.86 Bn | - | 1.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.34 Mn |
| Mar 31, 2026 | 15.86 Mn |
| Dec 31, 2025 | 2.07 Mn |
| Sep 30, 2025 | -4.80 Mn |
| Jun 30, 2025 | 14.64 Mn |
| Mar 31, 2025 | -5.74 Mn |
| Dec 31, 2024 | -7.84 Mn |
| Sep 30, 2024 | 11.28 Mn |
| Jun 30, 2024 | -13.55 Mn |
| Mar 31, 2024 | 15.92 Mn |
| Dec 31, 2023 | 3.92 Mn |
| Sep 30, 2023 | -177,000.00 |
| Jun 30, 2023 | -3.99 Mn |
| Mar 31, 2023 | -1.57 Mn |
| Dec 31, 2022 | 2.49 Mn |
| Sep 30, 2022 | 2.10 Mn |
| Jun 30, 2022 | 523,000.00 |
| Mar 31, 2022 | 694,000.00 |
| Dec 31, 2021 | -1.08 Mn |
| Sep 30, 2021 | -77,000.00 |
API Access
Viking Therapeutics Change in Accured Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=VKTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "VKTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=VKTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();